Bristol-Myers CEO Says the Company Is in Transition

Bristol-Myers CEO Christopher Boerner says the company is in transition, but he's excited about the strength of recent deals and drugs in their pipeline. He speaks on "Bloomberg Markets" from San Francisco. Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com Connect with us on... Twitter: https://twitter.com/business Facebook: https://www.facebook.com/bloombergbusiness/ Instagram: https://www.instagram.com/quicktake/?hl=en